CVS Group Plc (LSE:CVSG) — Market Cap & Net Worth
Market Cap & Net Worth: CVS Group Plc (CVSG)
CVS Group Plc (LSE:CVSG) has a market capitalization of $10.22 Million (GBX83.98 Billion) as of June 17, 2026. Listed on the LSE stock exchange, this UK-based company holds position #26999 globally and #351 in its home market, demonstrating a -2.84% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying CVS Group Plc's stock price GBX1197.00 by its total outstanding shares 70155929 (70.16 Million). Review CVS Group Plc balance sheet liabilities to assess the company's total debt and financial obligations.
CVS Group Plc Market Cap History: 2015 to 2026
CVS Group Plc's market capitalization history from 2015 to 2026. Data shows growth from $6.78 Million to $10.22 Million (6.12% CAGR).
Index Memberships
CVS Group Plc is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
FTSE AIM All Share Index
FTAI
|
$943.18 Million | 1.08% | #16 of 722 |
Weight: CVS Group Plc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
CVS Group Plc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how CVS Group Plc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.02x
CVS Group Plc's market cap is 0.02 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.57x
CVS Group Plc's market cap is 0.57 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $9.09 Million | $218.10 Million | $7.00 Million | 0.04x | 1.30x |
| 2017 | $8.61 Million | $271.80 Million | $11.50 Million | 0.03x | 0.75x |
| 2018 | $5.51 Million | $327.30 Million | $10.70 Million | 0.02x | 0.51x |
| 2019 | $9.58 Million | $406.50 Million | $8.20 Million | 0.02x | 1.17x |
| 2020 | $12.57 Million | $427.80 Million | $5.70 Million | 0.03x | 2.21x |
| 2021 | $18.80 Million | $510.10 Million | $19.30 Million | 0.04x | 0.97x |
| 2022 | $16.31 Million | $554.20 Million | $25.70 Million | 0.03x | 0.63x |
| 2023 | $14.25 Million | $588.90 Million | $41.90 Million | 0.02x | 0.34x |
| 2024 | $7.17 Million | $647.30 Million | $6.20 Million | 0.01x | 1.16x |
| 2025 | $10.96 Million | $673.20 Million | $19.30 Million | 0.02x | 0.57x |
Competitor Companies of CVSG by Market Capitalization
Companies near CVS Group Plc in the global market cap rankings as of June 17, 2026.
Key companies related to CVS Group Plc by market ranking:
- HCA Healthcare, Inc. (NYSE:HCA): Ranked #327 globally with a market cap of $80.16 Billion USD.
- FRESENIUS SE+CO. ADR 1/4 (F:FREA): Ranked #1003 globally with a market cap of $26.87 Billion USD ( €22.98 Billion EUR).
- Fresenius SE & Co. KGaA (XETRA:FRE): Ranked #1050 globally with a market cap of $25.53 Billion USD ( €21.84 Billion EUR).
- IHH Healthcare Bhd (KLSE:5225): Ranked #1333 globally with a market cap of $19.50 Billion USD ( RM77.67 Billion MYR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #327 | HCA Healthcare, Inc. | NYSE:HCA | $80.16 Billion | $396.93 |
| #1003 | FRESENIUS SE+CO. ADR 1/4 | F:FREA | $26.87 Billion | €10.20 |
| #1050 | Fresenius SE & Co. KGaA | XETRA:FRE | $25.53 Billion | €38.77 |
| #1333 | IHH Healthcare Bhd | KLSE:5225 | $19.50 Billion | RM8.79 |
CVS Group Plc Historical Marketcap From 2015 to 2026
Between 2015 and today, CVS Group Plc's market cap moved from $6.78 Million to $ 10.22 Million, with a yearly change of 6.12%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | GBX10.22 Million | -6.78% |
| 2025 | GBX10.96 Million | +52.86% |
| 2024 | GBX7.17 Million | -49.68% |
| 2023 | GBX14.25 Million | -12.62% |
| 2022 | GBX16.31 Million | -13.26% |
| 2021 | GBX18.80 Million | +49.55% |
| 2020 | GBX12.57 Million | +31.18% |
| 2019 | GBX9.58 Million | +74.01% |
| 2018 | GBX5.51 Million | -36.05% |
| 2017 | GBX8.61 Million | -5.32% |
| 2016 | GBX9.09 Million | +34.23% |
| 2015 | GBX6.78 Million | -- |
End of Day Market Cap According to Different Sources
On Jun 17th, 2026 the market cap of CVS Group Plc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $10.22 Million USD |
| MoneyControl | $10.22 Million USD |
| MarketWatch | $10.22 Million USD |
| marketcap.company | $10.22 Million USD |
| Reuters | $10.22 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About CVS Group Plc
CVS Group plc, together with its subsidiaries, engages in veterinary, online pharmacy, and retail businesses in the United Kingdom and Australia. It operates through the Veterinary Practices, Laboratories, and Online Retail Business segments. The company is involved in animal veterinary practices and complementary veterinary diagnostic businesses. It also operates Animed Direct, an online retail … Read more